Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

  • 5 Key Points You May Have Missed in Merck's Q2 Report - Motley Fool
    ... and rival immunotherapy from Bristol ... you might have missed is that blockbuster diabetes drug Januvia (known ... Should you buy Merck?
    07/31/2015 - 2:19 pm | View Link
  • Big Pharma Update: Merck (MRK) profit slashed in Q2 as Pfizer (PFE) ... - StockHouse USA
    Merck tops Street 2Q forecasts despite lower sales, profit - Sacramento Bee
    07/28/2015 - 4:57 am | View Link
  • Teva And Allergan Acquisition: Why Are Pharmaceutical Companies ... - International Business Times
    Ltd.  announced on Monday that it would buy the generic drug unit of ... in 2014 sales for Bristol-Myers ... treatment called Lantus for ...
    07/27/2015 - 12:53 pm | View Link
  • 3 Important Questions We Want Answered When Merck Reports Its Q2 ... - Motley Fool
    ... rival Opdivo from Bristol-Myers ... The deal to buy Cubist was designed to ... about whether or not Merck's blockbuster diabetes drug ...
    07/27/2015 - 9:04 am | View Link
  • Did McDonald's, Caterpillar & Amazon Lose Sizzle To Strong Dollar? - Yahoo! Finance
    ... s trading day are Bristol-Myers ... diabetes drugs Trulicity and Jardiance, and Cyramza, a new cancer drug ... from TD Ameritrade to buy, ...
    07/22/2015 - 3:27 pm | View Link
  • More
  • AstraZeneca to buy Bristol stake in diabetes venture for up to $4.1 bln
    Speculation that such a deal might be on the cards was fuelled last month after Bristol decided to exit diabetes drug research. The Bristol-AstraZeneca diabetes joint venture includes the oral medicines Onglyza, Kombiglyze and Forxiga, as well as the ...
    12/18/2013 - 8:18 pm | View Link
  • AstraZeneca to Buy Bristol’s Stake in Diabetes Joint Venture
    AstraZeneca (AZN) agreed on Thursday to buy Bristol-Myers Squibb’s ... an advisory panel recommended that the U.S. Food and Drug Administration approve dapagliflozin, an experimental treatment for Type 2 diabetes. A similar treatment from Johnson ...
    12/18/2013 - 7:00 pm | View Link
  • Bristol-Myers to buy diabetes drug maker for $5B
    NEW YORK (AP) -- Bristol-Myers Squibb Co. agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash, heating up the competition among drugmakers to develop diabetes treatments. After the deal is complete, Bristol-Myers will ...
    07/2/2012 - 1:21 pm | View Link
  • Bristol-Myers, AZ aim for diabetes glory with Amylin buy
    Now that Bristol-Myers Squibb ($BMY) and AstraZeneca ($AZN) have teamed up to buy Amylin Pharmaceuticals ($AMLN), the ... AstraZeneca will pay Bristol-Myers $3.4 billion for beefing up their current diabetes-drug alliance. Obviously, Astra and Bristol ...
    07/2/2012 - 4:27 am | View Link
  • Bristol-Myers to buy diabetes drug maker for $5 billion
    Bristol-Myers Squibb Co. said it plans to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash. Bristol-Myers will enter an agreement with British drug maker AstraZeneca to develop and commercialize Amylin's diabetes drugs ...
    07/2/2012 - 12:06 am | View Link
  • More
  • Bristol-Myers Squibb (BMS) – History, Products, Byetta ...
    Bristol-Myers Squibb (BMS) is one of the largest pharmaceutical companies in the world, with 28,000 employees and $16.4 billion in sales in 2013.
    08/27/2015 - 2:24 am | View Website
  • Health News & Articles | Healthy Living
    Get the latest health news from Dr. Richard Besser. Here you'll find stories about new medical research, the latest health care trends and health issues that affect ...
    08/26/2015 - 11:46 pm | View Website
  • Adult Type 2 Diabetes Medication |
    Read information about ONGLYZA® (saxagliptin), an adult type 2 diabetes medication used with diet and exercise to improve glycemic control.
    08/26/2015 - 11:46 pm | View Website
  • Bristol-Myers Squibb
    Bristol-Myers Squibb, often referred to as BMS, is an American pharmaceutical company, headquartered in New York City. Bristol-Myers Squibb manufactures prescription ...
    08/26/2015 - 11:11 pm | View Website
  • Generic Drugs
    Glucophage, for example, is Bristol-Myers Squibb’s brand of the drug whose generic name is metformin. For years, Glucophage was the only brand of metformin on the U ...
    08/26/2015 - 7:33 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News